{"doc_id": "si-2021-0008-reg-1", "parent_doc_id": "si-2021-0008", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 8 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "1. (1) These Regulations may be cited as the Medicinal Products", "text_raw": "1. (1) These Regulations may be cited as the Medicinal Products \n\n(Prescription and Control of Supply) (Amendment) (No. 2) Regulations 2021. \n\n(2) The collective citation “the Medicinal Products (Prescription and \n\nControl of Supply) Regulations 2003 to 2021” includes these Regulations.", "text_norm": "1 (1) regulation may cited medicinal product (prescription control supply) (amendment) (no 2) regulation 2021 (2) collective citation medicinal product (prescription control supply) regulation 2003 2021 includes regulation", "start_char": 636, "end_char": 926, "source_path": "downloads\\2021\\2021_0008.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80eed6a79f0073ad0d36243ee51da56d6e1990af708cfaf9b032846ca92363fb", "cross_refs": []}
{"doc_id": "si-2021-0008-reg-2", "parent_doc_id": "si-2021-0008", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 8 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "In these Regulations—", "text_raw": "2. \n\nIn these Regulations— \n\n“Principal Regulations” means the Medicinal Products (Prescription and \nControl of Supply) Regulations 2003 (S.I. No. 540 of 2003); \n\n“Regulations of 2021” means the Medicinal Products (Prescription and Control \nof Supply) (Amendment) Regulations 2021 (S.I. No. 2 of 2021).", "text_norm": "2 regulations-- principal regulation mean medicinal product (prescription control supply) regulation 2003 (s.i no 540 2003) regulation 2021 mean medicinal product (prescription control supply) (amendment) regulation 2021 (s.i no 2 2021)", "start_char": 926, "end_char": 1231, "source_path": "downloads\\2021\\2021_0008.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80eed6a79f0073ad0d36243ee51da56d6e1990af708cfaf9b032846ca92363fb", "cross_refs": []}
{"doc_id": "si-2021-0008-reg-3", "parent_doc_id": "si-2021-0008", "section_id": "reg-3", "section_label": "Regulation 3.", "si_number": "S.I. No. 8 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "3. The Eighth Schedule (as amended by Regulation 4 of the Regulations", "text_raw": "3. The Eighth Schedule (as amended by Regulation 4 of the Regulations \nof 2021) to the Principal Regulations is amended by inserting the following \nentry: \n\nNotice of the making of this Statutory Instrument was published in \n“Iris Oifigiúil” of 15th January, 2021. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f[8] 3 \n\n“ \n\nMedicinal \nProduct \n\nForm and \npresentation \nof product \nadministered \n\nRoute of \nadministratio\nn \n\nDosage and \nconditions of \nadministratio\nn \n\nPlace of \nadministratio\nn \n\nIndication \nfor which the \nmedicinal \nproduct may \nbe \nadministered \n\nColumn 1 \n\nColumn 2 \n\nColumn 3 \n\nColumn 4 \n\nColumn 5 \n\nColumn 6 \n\nDispersion for \ninjection in a \nmultidose \nvial. One dose \n(0.5 mL) \ncontains 100 \nmicrograms \nof messenger \nRNA \n(mRNA) \n(embedded in \nSM-102 lipid \nnanoparticles)\n. White to off \nwhite \ndispersion. \n\nCOVID-19 \nVaccine \nModerna \ndispersion \nfor \ninjection \n\nCOVID-19 \nmRNA \nVaccine \n(nucleosid\ne \nmodified) \n\n”. \n\nIntramuscular \n(IM) injection \n\nIndicated for \nactive \nimmunisatio\nn to prevent \nCOVID-19 \ncaused by \nSARS-CoV2 in \nindividuals \n18 years of \nage and \nolder. \n\nIn accordance \nwith the \nsummary of \nproduct \ncharacteristic\ns of the \nproduct \nadministered \nand relevant \nnational \nguidelines. \n\nAny suitable \nand \nappropriate \nplace, having \nregard to \npublic \nconvenience \nand the need \nto protect the \nhealth and \nsafety of the \npublic and \nsafely \nadminister the \nproduct. \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\f4 [8]", "text_norm": "3 eighth schedule (as amended regulation 4 regulation 2021) principal regulation amended inserting following entry notice making statutory instrument published iris oifigiuil 15th january 2021 8 3 medicinal product form presentation product administered route administratio n dosage condition administratio n place administratio n indication medicinal product may administered column 1 column 2 column 3 column 4 column 5 column 6 dispersion injection multidose vial one dose (0.5 ml) contains 100 microgram messenger rna (mrna) (embedded sm-102 lipid nanoparticles)  white white dispersion covid-19 vaccine moderna dispersion injection covid-19 mrna vaccine (nucleosid e modified)  intramuscular (im) injection indicated active immunisatio n prevent covid-19 caused sars-cov2 individual 18 year age older accordance summary product characteristic product administered relevant national guideline suitable appropriate place regard public convenience need protect health safety public safely administer product 4 8", "start_char": 1231, "end_char": 2697, "source_path": "downloads\\2021\\2021_0008.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80eed6a79f0073ad0d36243ee51da56d6e1990af708cfaf9b032846ca92363fb", "cross_refs": []}
{"doc_id": "si-2021-0008-reg-4", "parent_doc_id": "si-2021-0008", "section_id": "reg-4", "section_label": "Regulation 4.", "si_number": "S.I. No. 8 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "4. The Twelfth Schedule (as amended by Regulation 5 of the Regulations", "text_raw": "4. The Twelfth Schedule (as amended by Regulation 5 of the Regulations \nof 2021) to the Principal Regulations is amended by inserting the following \nentry: \n\n“ \n\nMedicinal \nProduct \n\nRoute of \nadministration \n\nForm and \npresentation \nof product \nadministered \n\nDosage and \nconditions of \nadministration \n\nIndication for \nwhich the \nmedicinal \nproduct may \nbe \nadministered \n\nColumn 1 Column 2 \n\nColumn 3 \n\nColumn 4 \n\nColumn 5 \n\nIntramuscular \n(IM) injection \n\nCOVID-19 \nVaccine \nModerna \ndispersion \nfor \ninjection \n\nCOVID-19 \nmRNA \nVaccine \n(nucleoside \nmodified) \n\nDispersion for \ninjection in a \nmultidose \nvial. One dose \n(0.5 mL) \ncontains 100 \nmicrograms of \nmessenger \nRNA (mRNA) \n(embedded in \nSM-102 lipid \nnanoparticles). \nWhite to off \nwhite \ndispersion. \n\nIn accordance \nwith the \nsummary of \nproduct \ncharacteristics \nof the product \nadministered \nand relevant \nnational \nguidelines. \n\nIndicated for \nactive \nimmunisation \nto prevent \nCOVID-19 \ncaused by \nSARS-CoV2 in \nindividuals \n18 years of \nage and \nolder. \n\n.”. \n\nGIVEN under my Official Seal, \n\n13 January, 2021. \n\nSTEPHEN DONNELLY, \nMinister for Health. \n\n \n \n \n \n \n \n \n \n \n\f[8] 5", "text_norm": "4 twelfth schedule (as amended regulation 5 regulation 2021) principal regulation amended inserting following entry medicinal product route administration form presentation product administered dosage condition administration indication medicinal product may administered column 1 column 2 column 3 column 4 column 5 intramuscular (im) injection covid-19 vaccine moderna dispersion injection covid-19 mrna vaccine (nucleoside modified) dispersion injection multidose vial one dose (0.5 ml) contains 100 microgram messenger rna (mrna) (embedded sm-102 lipid nanoparticles) white white dispersion accordance summary product characteristic product administered relevant national guideline indicated active immunisation prevent covid-19 caused sars-cov2 individual 18 year age older   given official seal 13 january 2021 stephen donnelly minister health 8 5", "start_char": 2697, "end_char": 3851, "source_path": "downloads\\2021\\2021_0008.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80eed6a79f0073ad0d36243ee51da56d6e1990af708cfaf9b032846ca92363fb", "cross_refs": []}
{"doc_id": "si-2021-0008-explanatory-note", "parent_doc_id": "si-2021-0008", "section_id": "explanatory-note", "section_label": "EXPLANATORY NOTE", "si_number": "S.I. No. 8 of 2021", "title": "Medicines Board (Miscellaneous Provisions) Act 2006 (No. 3 of 2006)) of the", "year": 2021, "heading": "(This note is not part of the Instrument and does not purport to be a legal", "text_raw": "EXPLANATORY NOTE \n\n(This note is not part of the Instrument and does not purport to be a legal \ninterpretation.) \n\nThese Regulations amend the Medicinal Products (Prescription and Control of \nSupply) Regulations 2003. \n\nThe purpose of these Regulations is to add an additional Covid-19 vaccination \nto the Eighth and Twelfth Schedules to the Regulations of 2003. \n\nThese Regulations may be cited as the Medicinal Products (Prescription and \nControl of Supply) (Amendment) (No. 2) Regulations 2021. \n\n \n \n \n \n \n \n \n\f6 [8] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \n52 FAICHE STIABHNA, BAILE ÁTHA CLIATH 2, \nD02 DR67. \n\nTeil: 076 110 6834 \nr-post: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \n52 ST. STEPHEN'S GREEN, DUBLIN 2, \nD02 DR67. \n\nTel: 076 110 6834 \nE-mail: publications@opw.ie \n—————— \n\n€ 3.00 \n\n(DH-191) 75. 1/21. Propylon.", "text_norm": "explanatory note (this note part instrument purport legal interpretation.) regulation amend medicinal product (prescription control supply) regulation 2003 purpose regulation add additional covid-19 vaccination eighth twelfth schedule regulation 2003 regulation may cited medicinal product (prescription control supply) (amendment) (no 2) regulation 2021 6 8 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais 52 faiche stiabhna baile atha cliath 2 d02 dr67 teil 076 110 6834 r-post publication opw.ie ------------ dublin published stationery office purchased government publication 52 st stephen green dublin 2 d02 dr67 tel 076 110 6834 e-mail publication opw.ie ------------ eur 3.00 (dh-191) 75 1 21 propylon", "start_char": 3851, "end_char": 4823, "source_path": "downloads\\2021\\2021_0008.pdf", "extraction_method": "pdfminer", "checksum": "sha256:80eed6a79f0073ad0d36243ee51da56d6e1990af708cfaf9b032846ca92363fb", "cross_refs": []}
